Disclosures: Sudeep Tanwar: Nothing to Disclose, Walter Gregory: Nothing to Disclose, The ELUCIDATE Investigators: Nothing to Disclose, Peter Selby: Nothing to Disclose, William Rosenberg: Nothing to Disclose 2039 SERUM THROMBOSPONDIN 2 AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 PREDICT ADVANCED LIVER FIBROSIS IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY Rambabu Surabattula 1 Valentina Strohmeier 2 Anna-Maria Globig 2 Sudha Myneni 1 Maximilian Heeg 2 Gerhard Kindle 2 Sigune Goldacker 2 Caroline von Spee-Mayer 2 Michele Proietti 3 Birke Bausch 2 Dominik Bettinger 2 Michael Schulthei 2 Robert Thimme 2 Klaus Warnatz 2 Detlef Schuppan 1 , 1 University Medical Center Mainz, 2 University Medical Center Freiburg, 3 Hannover Medical School Background: Timely detection of segmental fibrosis and portal hypertension as a manifestation in a significant subgroup of patients with CVID (Common Variable Immunodeficiency) is a challenge, as it is usually not associated with classic liver cirrhosis
Ann Clin Lab Sci 2015;45:287291
The physiological or therapeutic significance of GLP-1 RA engagement at these peripheral sites remains unclear and warrants further investigation
The incretin hormone glucagonlike peptide 1 increases mitral cell excitability by decreasing conductance of a voltagedependent potassium channel
When blood glucose remains persistently high, as it does in poorly managed diabetes, it causes microvascular damage throughout the body
,aspect=ignore)
,aspect=ignore)
,aspect=ignore)
